Skip to main content
SpringerLink
Log in

Serum Zinc and Haptoglobin in Noncirrhotic Azeri Patients with Chronic Active Hepatitis C: a Case–Control Study

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The aim of present study was to compare levels of serum zinc and haptoglobin between patients with chronic active hepatitis C and controls. Two groups including Azeri patients with chronic active hepatitis C (n = 274) and their healthy family members (n = 100) were studied. Serum zinc and haptoglobin were measured using colorimetric and nephelometric methods, respectively. Patients were 156 males (56.9 %) and 118 females (43.1 %) with the mean age of 40.15 ± 12.24 years. Controls were 56 males (56 %) and 44 females (44 %) with the mean age of 39.32 ± 4.40 (p = 0.87 for sex and 0.51 for age). Both the mean levels of serum zinc (72.04 ± 19.08 vs. 106.18 ± 25.52 μg/dL) and haptoglobin (0.72 ± 0.45 vs. 1.08 ± 0.34 g/L) were significantly lower in patients than in controls (p < 0.001 for both comparisons). Serum zinc concentration was significantly higher in males and did not correlate significantly with age, serum glutamic pyruvic transaminase (SGPT), or serum glutamic oxaloacetic transaminase (SGOT). Serum haptoglobin did not differ significantly between males and females, and it correlated significantly with age (r = −0.20), serum SGPT (r = −0.22), and SGOT (r = −0.20). This study showed lower levels of serum zinc and haptoglobin in patients with chronic hepatitis C than in controls. Major confounding factors in previous studies were left out.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Mohammad MK, Zhou Z, Cave M, Barve A, McClain CJ (2012) Zinc and liver disease. Nutr Clin Pract: Off Publ Am Soc Parenter Enter Nutr 27(1):8–20. doi:10.1177/0884533611433534

    Article  Google Scholar 

  2. Dardenne M (2002) Zinc and immune function. Eur J Clin Nutr 56(Suppl 3):S20–23. doi:10.1038/sj.ejcn.1601479

    Article  CAS  PubMed  Google Scholar 

  3. Stamoulis I, Kouraklis G, Theocharis S (2007) Zinc and the liver: an active interaction. Dig Dis Sci 52(7):1595–1612. doi:10.1007/s10620-006-9462-0

    Article  CAS  PubMed  Google Scholar 

  4. Grungreiff K, Reinhold D (2010) Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review). Molecular Med Reports 3(3):371–375. doi:10.3892/mmr_00000267

    Article  Google Scholar 

  5. Davis GL, Albright JE, Cook SF, Rosenberg DM (2003) Projecting future complications of chronic hepatitis C in the United States. Liver Transplan: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 9(4):331–338. doi:10.1053/jlts.2003.50073

    Article  Google Scholar 

  6. Nazari MA, Malayeri SH, Pourhoseingholi MA, Mohebi SR, Zali MR (2010) Evaluation of zinc plasma level in Iranian cirrhotic patients due to hepatitis B and hepatitis C. Hepat Mon 10(1):62–64

    PubMed Central  PubMed  Google Scholar 

  7. Himoto T, Hosomi N, Nakai S, Deguchi A, Kinekawa F, Matsuki M, Yachida M, Masaki T, Kurokochi K, Watanabe S, Senda S, Kuriyama S (2007) Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scand J Gastroenterol 42(9):1078–1087. doi:10.1080/00365520701272409

    Article  CAS  PubMed  Google Scholar 

  8. Himoto T, Yoneyama H, Deguch A, Kurokohchi K, Inukai M, Masugata H, Goda F, Senda S, Watanabe S, Kubota S, Kuriyama S, Masaki T (2010) Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis C. Exp Ther Med 1(4):707–711. doi:10.3892/etm_00000109

    PubMed Central  CAS  PubMed  Google Scholar 

  9. Cesur S, Cebeci SA, Kavas GO, Yilmaz N, Buyukkagnici DI (2005) Serum copper and zinc concentrations in patients with chronic hepatitis C. J Infect 51(1):35–37. doi:10.1016/j.jinf.2004.08.003

    Article  PubMed  Google Scholar 

  10. Grungreiff K, Hebell T, Gutensohn K, Reinhold A, Reinhold D (2009) Plasma concentrations of zinc, copper, interleukin-6 and interferon-gamma, and plasma dipeptidyl peptidase IV activity in chronic hepatitis C. Molecular Med Reports 2(1):63–68. doi:10.3892/mmr_00000062

    Google Scholar 

  11. Kim KI, Kim SR, Sasase N, Akimoto Y, Shikata M, Ohtani A, Hirooka T, Tanaka K (2008) Blood cell, liver function, and response changes by PEG-interferon-alpha2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C. Hepatol Int 2(1):111–115. doi:10.1007/s12072-007-9029-y

    Article  PubMed Central  PubMed  Google Scholar 

  12. Kolachi NF, Kazi TG, Afridi HI, Kazi NG, Mughal MA, Khan S (2013) Effects of selenium and zinc status in biological samples of hepatitis C patient after herbal and pharmaceutical supplements. Biol Trace Elem Res 152(2):187–194. doi:10.1007/s12011-013-9617-8

    Article  CAS  PubMed  Google Scholar 

  13. Hambidge KM, Krebs NF (2007) Zinc deficiency: a special challenge. J Nutr 137(4):1101–1105

    CAS  PubMed  Google Scholar 

  14. Lopes PA, Santos MC, Vicente L, Rodrigues MO, Pavao ML, Neve J, Viegas-Crespo AM (2004) Trace element status (Se, Cu, Zn) in healthy Portuguese subjects of Lisbon population: a reference study. Biol Trace Elem Res 101(1):1–17. doi:10.1385/BTER:101:1:01

    Article  CAS  PubMed  Google Scholar 

  15. Moneib HA, Salem SA, Darwish MM (2010) Evaluation of zinc level in skin of patients with necrolytic acral erythema. Br J Dermatol 163(3):476–480. doi:10.1111/j.1365-2133.2010.09820.x

    Article  CAS  PubMed  Google Scholar 

  16. Maret W, Krezel A (2007) Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol Med 13(7–8):371–375. doi:10.2119/2007-00036.Maret

    PubMed Central  CAS  PubMed  Google Scholar 

  17. Lin CC, Huang JF, Tsai LY, Huang YL (2006) Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res 109(1):15–24. doi:10.1385/BTER:109:1:015

    Article  CAS  PubMed  Google Scholar 

  18. Kalkan A, Bulut V, Avci S, Celik I, Bingol NK (2002) Trace elements in viral hepatitis. J Trace Elem Med Biol: Organ Soc Miner Trace Elem 16(4):227–230. doi:10.1016/S0946-672X(02)80049-9

    Article  CAS  Google Scholar 

  19. Takagi H, Nagamine T, Abe T, Takayama H, Sato K, Otsuka T, Kakizaki S, Hashimoto Y, Matsumoto T, Kojima A, Takezawa J, Suzuki K, Sato S, Mori M (2001) Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. J Viral Hepat 8(5):367–371

    Article  CAS  PubMed  Google Scholar 

  20. Ebara M, Fukuda H, Hatano R, Yoshikawa M, Sugiura N, Saisho H, Kondo F, Yukawa M (2003) Metal contents in the liver of patients with chronic liver disease caused by hepatitis C virus. Reference to hepatocellular carcinoma. Oncology 65(4):323–330

    Article  CAS  PubMed  Google Scholar 

  21. Kormoczi GF, Saemann MD, Buchta C, Peck-Radosavljevic M, Mayr WR, Schwartz DW, Dunkler D, Spitzauer S, Panzer S (2006) Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Investig 36(3):202–209. doi:10.1111/j.1365-2362.2006.01617.x

    Article  CAS  Google Scholar 

  22. Volchkova EV, Pak SG, Malov VA, Umbetova KT (2000) Changes in the levels of acute phase proteins in viral hepatitis. Ter Arkh 72(11):18–21

    CAS  PubMed  Google Scholar 

  23. Asazawa H, Kamada Y, Takeda Y, Takamatsu S, Shinzaki S, Kim Y, Nezu R, Kuzushita N, Mita E, Kato M, Miyoshi E (2015) Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development. Clin Chem Lab Med 53(1):95–102. doi:10.1515/cclm-2014-0427

    Article  CAS  PubMed  Google Scholar 

  24. Zhu J, Lin Z, Wu J, Yin H, Dai J, Feng Z, Marrero J, Lubman DM (2014) Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. J Proteome Res 13(6):2986–2997. doi:10.1021/pr500128t

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Abbasinazari M, Behnava B, Panahi Y, Hajhossein Talasaz A, Salimi S, Keshvari M, Mehrnoush L, Karim Elizee P, Gholami Fesharaki M, Asgharinia M, Alavian SM (2013) Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference? Hepat Mon 13(8):e11138. doi:10.5812/hepatmon.11138

    Article  PubMed Central  PubMed  Google Scholar 

  26. Bacq Y, Schillio Y, Brechot JF, De Muret A, Dubois F, Metman EH (1993) Decrease of haptoglobin serum level in patients with chronic viral hepatitis C. Gastroenterol Clin Biol 17(5):364–369

    CAS  PubMed  Google Scholar 

  27. Arain SA, Kazi TG, Afridi HI, Talpur FN, Mughal MA, Shah F, Arain SS, Panhwar AH (2014) Estimation of copper and iron burden in biological samples of various stages of hepatitis C and liver cirrhosis patients. Biol Trace Elem Res 160(2):197–205. doi:10.1007/s12011-014-0058-9

    Article  CAS  PubMed  Google Scholar 

  28. Arain SA, Afridi HI, Kazi TG, Talpur FN, Shah F, Arain SS, Panhwar AH, Brahman KD (2013) Investigation of alteration in the levels of iron and copper in scalp hair samples of patients having different types of viral hepatitis. Biol Trace Elem Res. doi:10.1007/s12011-013-9832-3

    Google Scholar 

  29. Arain SA, Kazi TG, Afridi HI, Abbasi AR, Panhwar AH, Naeemullah SB, Arain MB (2014) Application of dual-cloud point extraction for the trace levels of copper in serum of different viral hepatitis patients by flame atomic absorption spectrometry: a multivariate study. Spectrochim Acta A Mol Biomol Spectrosc 133:651–656. doi:10.1016/j.saa.2014.05.077

    Article  CAS  PubMed  Google Scholar 

  30. Kawaguchi T, Nagao Y, Abe K, Imazeki F, Honda K, Yamasaki K, Miyanishi K, Taniguchi E, Kakuma T, Kato J, Seike M, Yokosuka O, Ohira H, Sata M (2015) Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial. Mol Med Rep 11(3):2159–2166. doi:10.3892/mmr.2014.2943

    CAS  PubMed  Google Scholar 

  31. Abbasinazari M, Alavian SM, Behnava B, Asgharinia M, Salimi S, Keshvari M, Mehrnoush L, Karim P (2014) Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study. J Clin Diagn Res 8(12):HC16–19. doi:10.7860/JCDR/2014/10403.5305

    PubMed Central  PubMed  Google Scholar 

  32. Iwata K, Enomoto H, Nishiguchi S, Aizawa N, Sakai Y, Iwata Y, Tanaka H, Ikeda N, Takashima T, Saito M, Imanishi H, Iijima H, Tsuda Y, Higuchi K (2014) Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis. J Clin Biochem Nutr 55(2):147–152. doi:10.3164/jcbn. 14-33

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Mohamed AA, Abbassi MM, Hamed WA, EzzEl-Arab MA, Aref AM (2014) Can zinc levels predict response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 4 infected Egyptian patients? Acta Gastroenterol Belg 77(2):217–223

    PubMed  Google Scholar 

  34. Moriyama M, Matsumura H, Fukushima A, Ohkido K, Arakawa Y, Nirei K, Yamagami H, Kaneko M, Tanaka N, Arakawa Y (2006) Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease. Dig Dis Sci 51(11):1967–1977. doi:10.1007/s10620-005-9051-7

    Article  CAS  PubMed  Google Scholar 

  35. Overbeck S, Rink L, Haase H (2008) Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases. Arch Immunol Ther Exp 56(1):15–30. doi:10.1007/s00005-008-0003-8

    Article  CAS  Google Scholar 

  36. Matsuoka S, Matsumura H, Nakamura H, Oshiro S, Arakawa Y, Hayashi J, Sekine N, Nirei K, Yamagami H, Ogawa M, Nakajima N, Amaki S, Tanaka N, Moriyama M (2009) Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. J Clin Biochem Nutr 45(3):292–303. doi:10.3164/jcbn. 08-246

    Article  PubMed Central  PubMed  Google Scholar 

  37. Papanikolopoulos K, Alexopoulou A, Dona A, Hadziyanni E, Vasilieva L, Dourakis S (2014) Abnormalities in Cu and Zn levels in acute hepatitis of different etiologies. Hippokratia 18(2):144–149

    PubMed Central  CAS  PubMed  Google Scholar 

  38. Imai K, Beppu T, Yamao T, Okabe H, Hayashi H, Nitta H, Hashimoto D, Mima K, Nakagawa S, Sakamoto K, Chikamoto A, Ishiko T, Baba H (2014) Clinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomy. Ann Surg Oncol. doi:10.1245/s10434-014-3786-3

    Google Scholar 

  39. Murakami Y, Koyabu T, Kawashima A, Kakibuchi N, Kawakami T, Takaguchi K, Kita K, Okita M (2007) Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin. J Nutr Sci Vitaminol 53(3):213–218

    Article  CAS  PubMed  Google Scholar 

  40. Suzuki H, Takagi H, Sohara N, Kanda D, Kakizaki S, Sato K, Mori M, Gunma Liver Study G (2006) Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial. World J Gastroenterol: WJG 12(8):1265–1269

    PubMed Central  CAS  PubMed  Google Scholar 

  41. Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, Messous D, Degos F, group Gc (2002) Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 9(2):128–133

    Article  CAS  PubMed  Google Scholar 

  42. Fowkes FJ, Imrie H, Migot-Nabias F, Michon P, Justice A, Deloron P, Luty AJ, Day KP (2006) Association of haptoglobin levels with age, parasite density, and haptoglobin genotype in a malaria-endemic area of Gabon. AmJTrop Med Hyg 74(1):26–30

    CAS  Google Scholar 

  43. Rosenthal-Allieri MA, Tran A, Halfon P, Imbert-Bismut F, Munteanu M, Messous D, Peritore ML, Poynard T, Bernard A (2007) Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C. Gastroenterol Clin Biol 31(10):815–821

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors report no conflict of interests or external source of financial support.

Author information

Authors and Affiliations

  1. Department of Infectious Disease, Sina Teaching Hospital, Tabriz University of Medical Sciences, Tabriz, Iran

    Abolfazl Pourhassan

  2. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Daniel Fadaei Fouladi & Sam Morshedi Asl

  3. Department of Pathology, Qazvin University of Medical Sciences, Qazvin, Iran

    Simin Mirakhor Samani

Authors
  1. Abolfazl Pourhassan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Fadaei Fouladi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Simin Mirakhor Samani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sam Morshedi Asl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sam Morshedi Asl.

Additional information

Abolfazl Pourhassan holds a degree in MD, Department of Infectious Disease, Sina Teaching Hospital, Tabriz University of Medical Sciences

Daniel Fadaei Fouladi holds a degree in MD, Drug Applied Research Center, Tabriz University of Medical Sciences

Simin Mirakhor Samani holds a degree in MD, Department of Pathology, Qazvin University of Medical Sciences

Sam Morshedi Asl holds a degree in MD, Neurosciences Research Center, Tabriz University of Medical Sciences

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pourhassan, A., Fouladi, D.F., Samani, S.M. et al. Serum Zinc and Haptoglobin in Noncirrhotic Azeri Patients with Chronic Active Hepatitis C: a Case–Control Study. Biol Trace Elem Res 167, 187–193 (2015). https://doi.org/10.1007/s12011-015-0309-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-015-0309-4

Keywords

Search

Navigation